Lockdown 2.0: What Does This Mean For Drug Use?

  Covid-19 and mental health problems are two pandemics that have simultaneously collided.  The inextricable link between addiction and mental illness has been exacerbated by this pandemic. Spring lockdown saw a surge in drug consumption. In the midst of a second national lockdown, it is important to consider what implications this has on vulnerable populations … Continued

The Overwhelming Argument for Rescheduling Psilocybin to Schedule 2 in the Misuse of Drugs Regulations 2001.

  In July, the Conservative Drug Policy Reform Group (‘CDPRG’) produced the most compelling argument (so far) for rescheduling of psilocybin.[1]  It is now time to: Assess the impact of that argument contained in the CDPRG’s report: “Medicinal use of psilocybin: Reducing restrictions on research and treatment” (the ‘Medicinal Use Report’); and Restate and emphasise … Continued

Editorial: The Evolution of Advocacy

  Entering the drug reform space four years ago was a shock to the system. Despite years of working with the most complex and vulnerable populations in the UK, nothing had prepared me for the pure terror of a live TV interview on the BBC, or standing in front of hundreds of academics, thought leaders … Continued

Cannabis 2.0 Innovations: Drinks

  The changing legal status of cannabis, along with recognising its medical benefits has allowed the industry to continue to grow. As a result of this, alternative ways for consuming cannabis have started to emerge such as infused products. The market for cannabis-infused beverages has been growing steadily in popularity. In 2019, the North American … Continued